Malignant Melanoma

Showing 51 - 75 of 202

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Melanoma Trial in Amsterdam (Tilsotolimod, Saline (0.9% sodium chloride))

Recruiting
  • Malignant Melanoma
  • Amsterdam, Netherlands
    VU Medical Centere
Apr 14, 2021

Malignant Melanoma Trial in United States (BMS-936558 (MDX1106-04), Ipilimumab)

Completed
  • Malignant Melanoma
  • New Haven, Connecticut
  • +3 more
Mar 19, 2021

Malignant Melanoma Trial in Gothenburg (Neurofilament light protein measurement in Isolated limb perfused patients)

Completed
  • Malignant Melanoma
  • Neurofilament light protein measurement in Isolated limb perfused patients
  • Gothenburg, Sweden
    Sahlgrenska University Hospital
Mar 16, 2021

Malignant Melanoma Trial in Germany (Encorafenib, Binimetinib, Pembrolizumab)

Completed
  • Malignant Melanoma
  • Freiburg, Baden-Württemberg, Germany
  • +10 more
Feb 13, 2021

Malignant Melanoma Trial in France, Germany (Vemurafenib, Cobimetinib, Atezolizumab)

Terminated
  • Malignant Melanoma
  • Marseille, France
  • +6 more
Jan 29, 2021

Melanoma, Malignant Melanoma, Stage IIIA Melanoma Trial in Orange (procedure, other, drug)

Completed
  • Melanoma
  • +4 more
  • therapeutic conventional surgery
  • +3 more
  • Orange, California
    Chao Family Comprehensive Cancer Center
Dec 30, 2020

IL-2 "SELECT" Tissue Collection Protocol in Advanced Melanoma

Completed
  • Malignant Melanoma
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 13, 2021

Malignant Melanoma Trial in Shanghai (Camrelizumab for injection)

Recruiting
  • Malignant Melanoma
  • Camrelizumab for injection
  • Shanghai, Shanghai, China
  • +1 more
Dec 20, 2020

Activity of Immune Checkpoint Inhibitor Therapy in Advanced

Recruiting
  • Malignant Melanoma
    • Jette, Brabant, Belgium
    • +1 more
    Dec 16, 2020

    Suction Drain in Axillary Lymph Node Dissection for Malignant

    Completed
    • Malignant Melanoma
      • Graz, Styria, Austria
        Medical University of Graz
      Nov 23, 2020

      NSCLC, Urothelial Carcinoma, Malignant Melanoma Trial in Aurora, Lake Mary, Philadelphia (CAN04, Pembrolizumab)

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • +3 more
      • Aurora, Colorado
      • +2 more
      Nov 17, 2020

      Malignant Melanoma, Recurrent Melanoma Trial (Dacarbazine, Fotemustine, Interferon Alfa-2b)

      Completed
      • Malignant Melanoma
      • Recurrent Melanoma
      • (no location specified)
      Oct 18, 2020

      Malignant Melanoma, Nevus, Pigmented, Basal Cell Carcinoma Trial in Copenhagen (optical coherence tomography)

      Unknown status
      • Malignant Melanoma
      • +3 more
      • optical coherence tomography
      • Copenhagen, Denmark
        Dept of Dermatology
      Nov 2, 2020

      Malignant Melanoma Trial in New York (Imiquimod, NY-ESO-1 protein)

      Completed
      • Malignant Melanoma
      • New York, New York
        NYU Cancer Institute
      Sep 28, 2020

      Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

      Terminated
      • Malignant Melanoma
      • +7 more
      • Gilbert, Arizona
      • +29 more
      Sep 21, 2020

      Malignant Melanoma Trial in Germany (Dabrafenib, Trametinib)

      Terminated
      • Malignant Melanoma
      • Heidelberg, BW, Germany
      • +5 more
      Oct 13, 2020

      Malignant Melanoma Trial in Worldwide (Placebo, Vemurafenib, Cobimetinib)

      Completed
      • Malignant Melanoma
      • Placebo
      • +2 more
      • Birmingham, Alabama
      • +155 more
      Sep 14, 2020

      Advanced Ovarian Cancer, Malignant Melanoma Trial in Toronto (drug, procedure, biological)

      Completed
      • Advanced Ovarian Cancer
      • Malignant Melanoma
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Aug 12, 2020

      Malignant Melanoma Trial in New York, Oxford, Glasgow (IMCgp100)

      Terminated
      • Malignant Melanoma
      • New York, New York
      • +2 more
      Jul 1, 2020

      Malignant Melanoma Trial (Fluvastatin, RNA-sequencing, Gene expression profiling)

      Withdrawn
      • Malignant Melanoma
      • (no location specified)
      Jul 23, 2020

      Malignant Melanoma Trial in United States (Atezolizumab, Cobimetinib, Vemurafenib)

      Completed
      • Malignant Melanoma
      • Los Angeles, California
      • +7 more
      Jul 20, 2020

      Malignant Melanoma Trial in United Kingdom, United States (IMCgp100)

      Completed
      • Malignant Melanoma
      • Los Angeles, California
      • +8 more
      Jul 1, 2020

      Malignant Melanoma Trial in Tampa (HyperAcute-Melanoma Vaccine)

      Completed
      • Malignant Melanoma
      • HyperAcute-Melanoma Vaccine
      • Tampa, Florida
        H. Lee Moffitt Cancer Center & Research Institute
      May 26, 2020

      Malignant Melanoma Trial (Pembrolizumab, Carboplatin, Paclitaxel)

      Completed
      • Malignant Melanoma
      • Pembrolizumab
      • +4 more
      • (no location specified)
      Apr 29, 2020

      Malignant Melanoma, Adjuvant Drug Therapy, Vaccin Therapy Trial in Meldola (FC), Meldola (Autologous Dendritic Cell vaccine)

      Terminated
      • Malignant Melanoma
      • +2 more
      • Autologous Dendritic Cell vaccine
      • Meldola (FC), FC, Italy
      • +1 more
      Apr 20, 2020